Skip to main content
logo
Ingenia Therapeutics Inc. (KOSDAQ:950260)
South Korea flag South Korea · Delayed Price · Currency is KRW
18,470
+540 (3.01%)
At close: Sep 18, 2026

Ingenia Therapeutics Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Income
-22,377-26,44821,458
Depreciation & Amortization
1,1811,041305.18
Loss (Gain) From Sale of Assets
--1.08
Loss (Gain) From Sale of Investments
-814.39-4,676-43,807
Stock-Based Compensation
1,8011,252898.97
Other Operating Activities
-1,439-4,5184,194
Change in Accounts Receivable
39.25717.45-735
Change in Other Net Operating Assets
4,1531,369-2,092
Operating Cash Flow
-17,456-31,262-19,777
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Capital Expenditures
-1,047-780.1-278.61
Sale of Property, Plant & Equipment
--0.99
Sale (Purchase) of Intangibles
-308.3--220.5
Investment in Securities
19,31736,5423,605
Other Investing Activities
-49.178.35-311.56
Investing Cash Flow
17,91335,8402,795

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Long-Term Debt Repaid
--762.59-
Net Debt Issued (Repaid)
-768.07-762.59-
Issuance of Common Stock
693.25808.75612.23
Financing Cash Flow
-74.8246.1615,312

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Foreign Exchange Rate Adjustments
41.35-7.2-0.65
Miscellaneous Cash Flow Adjustments
00-
Net Cash Flow
423.744,617-1,670

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Free Cash Flow
-18,503-32,042-20,056
Free Cash Flow Growth
---
Free Cash Flow Margin
-249.39%--568.06%
Free Cash Flow Per Share
-667.64-2360.00-472.00
Levered Free Cash Flow
--20,992-
Unlevered Free Cash Flow
--20,880-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash Interest Paid
248.78178.38-
Cash Income Tax Paid
-2,0686,814
Change in Working Capital
4,1922,087-2,827